人类免疫缺陷病毒(HIV)
叙述性评论
艾滋病疫苗
病毒学
医学
免疫学
生物
重症监护医学
疫苗试验
作者
Amir Ghaffari Jolfayi,Shiva Alipour,Sarina Aminizadeh,Seyyed Mohammad Yaghoubi,Sepideh Sohrabi,Zahra Ghahramanipour,Amir Azimi,Fateme Yousefimoghadam,Behzad Baradaran
出处
期刊:Vaccine
[Elsevier BV]
日期:2025-06-02
卷期号:61: 127340-127340
被引量:2
标识
DOI:10.1016/j.vaccine.2025.127340
摘要
Significant challenges are presented as a result of the ongoing HIV/AIDS pandemic, particularly given the ongoing burden of new infections and the lack of a proven treatment. Among other approaches, vaccinations based on Dendritic Cells (DCs) have become a viable tactic in the fight against HIV. These vaccines take advantage of DCs' special capacity to deliver antigens, which makes them crucial mediators between innate and adaptive immune responses. DC-based vaccines seek to offer a prolonged and effective protection against the virus by stimulating immunological responses against HIV-infected cells and activating cytotoxic T lymphocytes (CTLs). This narrative review highlights the recent advancements in DC-based vaccine development for HIV/AIDS. It explores various vaccine strategies, including DC/SHIV fusion vaccines, peptide-pulsed DC vaccines, mRNA-based DC vaccines, and lentiviral vector-modified DC vaccines. These methods have shown promise in preclinical and clinical trials by eliciting strong immune responses, especially by activating HIV-specific T cells and modulating immune checkpoints like PD-1/PD-L1 and CTLA-4. The review emphasizes how these vaccines can enhance immune responses, reduce viral load, and potentially contribute to a functional cure for HIV. This study aims to offer a thorough update on the process and obstacles in DC-based vaccine development for HIV/AIDS. This review also addresses clinical trials and future directions for optimizing these vaccines' safety, efficacy, and scalability for global application. Through an in-depth analysis of the mechanisms, clinical outcomes, and potential of DC-based vaccines, this paper underscores their promising prospects as an essential element of a comprehensive HIV eradication strategy worldwide.
科研通智能强力驱动
Strongly Powered by AbleSci AI